Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UFP TechnologiesFRA:UFP -0.45%96 EV-to-EBIT is 22.98 as of Aug. 01, 2026, which is 17% above its 10-year median of 19.68. GuruFocus rates FRA:UFP with a GF Score™ of 96/100 and a GF Value™ of €235.59 (Fairly Valued). The stock has 7 warning signs investors should review. Among 467 Medical Devices & Instruments companies, UFP Technologies ranks worse than 62.1% on this metric.
The historical rank and industry rank for UFP Technologies's EV-to-EBIT or its related term are showing as below:
FRA:UFP'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.69 Med: 19.68 Max: 45.59
Current: 22.76
During the past 13 years, the highest EV-to-EBIT of UFP Technologies was 45.59. The lowest was 10.69. And the median was 19.68.
FRA:UFP's EV-to-EBIT is ranked worse than 62.1% of 467
companies
in the Medical Devices & Instruments industry
Industry Median: 18.66
vs FRA:UFP: 22.76
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
UFP Technologies's Enterprise Value for the quarter that ended in Mar. 2026 was €1,371.9 Mil.
UFP Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €79.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UFP Technologies EV-to-EBIT Related Terms
UFP Technologies EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for UFP Technologies's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:UFP vs ALMR, BFLY, NEOG: EV-to-EBIT Comparison
For the Medical Devices subindustry, UFP Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UFP Technologies EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where UFP Technologies's EV-to-EBIT falls into.
UFP Technologies's current Enterprise Value is €1,828.7 Mil.
UFP Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €79.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UFP Technologies (FRA:UFP) has a EV-to-EBIT of 22.98 as of Aug. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on UFP Technologies and its competitors. This is 17% above median its historical median of 19.68. Over the past decade, UFP Technologies' EV-to-EBIT has ranged from 10.69 to 45.59. According to the industry distribution chart, UFP Technologies ranks #290 out of 467 companies in the Medical Devices & Instruments industry, placing it in the top 62.1%.
Is UFP Technologies' EV-to-EBIT too high?
UFP Technologies' current EV-to-EBIT of 22.98 is 17% above median its 10-year median of 19.68. Over the past 10 years, this metric has ranged from a low of 10.69 to a high of 45.59. The Medical Devices & Instruments industry median EV-to-EBIT is 18.66. UFP Technologies' value of 22.98 is 23.2% above this industry median. Based on the distribution chart, UFP Technologies ranks #290 out of 467 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, UFP Technologies has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UFP Technologies' EV-to-EBIT compare to ALMR and BFLY?
According to the Medical Devices & Instruments industry distribution chart, UFP Technologies ranks #290 out of 467 companies for EV-to-EBIT. This places UFP Technologies in the lower half of its industry. The industry median EV-to-EBIT is 18.66. UFP Technologies' value of 22.98 is 23.2% above this benchmark. Historically, UFP Technologies' own EV-to-EBIT has ranged from 10.69 to 45.59 over the past decade. While the company's 10-year median is 19.68 vs. the industry median of 18.66, UFP Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.66, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UFP Technologies's current EV-to-EBIT of 22.98 is 23.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on UFP Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UFP Technologies's current EV-to-EBIT is 22.98, which is 17% above median its own 10-year median of 19.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UFP Technologies stock overvalued right now?
Based on GuruFocus' analysis, UFP Technologies (FRA:UFP) is currently considered Fairly Valued. The stock's GF Value™ is €235.59, compared to a current price of €220.80 — trading 6.3% below its estimated fair value. The current EV-to-EBIT is 22.98, which is 17% above median its 10-year median of 19.68 and 23.2% above the Medical Devices & Instruments industry median of 18.66. UFP Technologies' overall GF Score™ is 96/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For UFP Technologies (FRA:UFP), the current EV-to-EBIT is 22.98 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UFP Technologies (FRA:UFP) Overvalued in 2026?
Based on GuruFocus' analysis, UFP Technologies stock appears to be undervalued.
The current stock price of €220.80 is trading 6.3% below its estimated GF Value™ of €235.59.
GuruFocus considers UFP Technologies to be Fairly Valued.
Key valuation signals for FRA:UFP:
EV-to-EBIT: 22.98 (17% above median its 10-year median of 19.68)
GF Value™: €235.59 vs. price of €220.80 (6.3% below fair value)
Industry Position: 23.2% above the Medical Devices & Instruments median (#290 of 467)
No single metric tells the full story. See the FRA:UFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
96GF Score
Get the complete analysis for FRA:UFP
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UFP has been successfully added to your 
